Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$149.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jun 3 | ANIK | Anika Therapeutics, Inc. | MEXER | 12,840 | — | — | +34.8% | Open the original filing on SEC.gov |
| Apr 30 | ANIK | Anika Therapeutics, Inc. | PBUY | 12,200 | $12.29 | $149.9K | +50.9% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | MEXER◆ | 12,824 | — | — | — | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | FTAX | 5,944 | $14.20 | $84.4K | -19.9% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | AGRANT | 6,412 | — | — | +27.3% | Open the original filing on SEC.gov |
| Mar 14 | ANIK | Anika Therapeutics, Inc. | MEXER | 12,824 | — | — | +120.2% | Open the original filing on SEC.gov |
| Feb 1 | ANIK | Anika Therapeutics, Inc. | AGRANT◆ | 130,402 | — | — | — | Open the original filing on SEC.gov |
| Feb 1 | ANIK | Anika Therapeutics, Inc. | AGRANT◆ | 310,207 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | ANIK | Anika Therapeutics, Inc. | MEXER◆ | 12,840 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | ANIK | Anika Therapeutics, Inc. | FTAX | 3,769 | $11.59 | $43.7K | -27.6% | Open the original filing on SEC.gov |
| Jun 3, 2025 | ANIK | Anika Therapeutics, Inc. | MEXER | 12,840 | — | — | +1,605% | Open the original filing on SEC.gov |